Parasite strain specificity of precursor cytotoxic T cells in individual animals correlates with cross-protection in cattle challenged with Theileria parva by Taracha, Evans L. N. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parasite strain specificity of precursor cytotoxic T cells in
individual animals correlates with cross-protection in cattle
challenged with Theileria parva
Citation for published version:
Taracha, ELN, Goddeeris, B, Morzaria, SP & Morrison, I 1995, 'Parasite strain specificity of precursor
cytotoxic T cells in individual animals correlates with cross-protection in cattle challenged with Theileria
parva' Infection and Immunity, vol 63, no. 4, pp. 1258-62.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher final version (usually the publisher pdf)
Published In:
Infection and Immunity
Publisher Rights Statement:
Copyright 1995, American Society for Microbiology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
INFECTION AND IMMUNITY, Apr. 1995, p. 1258–1262 Vol. 63, No. 4
0019-9567/95/$04.0010
Copyright q 1995, American Society for Microbiology
Parasite Strain Specificity of Precursor Cytotoxic T Cells in
Individual Animals Correlates with Cross-Protection in Cattle
Challenged with Theileria parva
EVANS L. N. TARACHA,* BRUNO M. GODDEERIS,† SUBHASH P. MORZARIA,
AND W. IVAN MORRISON‡
International Laboratory for Research on Animal Diseases (ILRAD), Nairobi, Kenya
Received 11 November 1994/Returned for modification 20 December 1994/Accepted 18 January 1995
Class I major histocompatibility complex-restricted parasite-specific cytotoxic T lymphocytes (CTL) are
known to be a major component of the bovine immune response to the protozoan parasite Theileria parva, but
formal proof for their role in protection of cattle against infection with T. parva has been lacking. Animals
immunized with one stock of T. parva show variations in the degree of protection against heterologous challenge
and also in the parasite strain specificity of their CTL responses. The present study investigated the relation-
ship of strain specificity of CTL responses and cross-protection in an effort to verify the role of CTL in
protection. The parasite strain specificity of the CTL responses generated in 23 cattle immunized with either
of two immunologically distinct parasite populations was examined, and the susceptibility of individual cattle
to challenge with the heterologous parasite population was determined. The frequency of stock-specific or
cross-reactive CTL precursor cells (CTLp) in individual animals was measured by a limiting-dilution microas-
say. A proportion of animals immunized with either parasite exhibited cross-reactive CTLp, whereas CTLp
detected in the remaining animals were specific for the homologous parasite. On challenge with the heterol-
ogous stock, those animals with cross-reactive CTLp were solidly protected while those with strain-specific
CTLp showed moderate to severe reactions, although many of them recovered. The finding of a close associ-
ation between strain specificity of the CTL response and protection against challenge provides strong evidence
that CTL are important in mediating immunity.
Class I major histocompatibility complex (MHC)-restricted
cytotoxic T-lymphocyte (CTL) responses have been demon-
strated to occur in a number of intracellular protozoan para-
sitic infections of humans and animals. These responses have
been most extensively studied in human and rodent infections
with Plasmodium species (12, 13) and in cattle infected with
Theileria parva (18). Although there is evidence that CTL re-
sponses can confer protection in murine models of malaria, the
precise role of these responses in immunity to the natural
human and bovine diseases has yet to be determined. T. parva
causes an acute and usually fatal disease of cattle that occurs
throughout a large part of eastern, central, and southern Africa
(3). The parasite at the sporozoite stage infects lymphocytes
after inoculation by the tick vector and induces them to pro-
liferate; simultaneous division of the schizont stage parasite
and the infected cell results in a clonal expansion of parasitized
cells (10), which become disseminated throughout the lym-
phoid system and certain nonlymphoid organs such as the
lungs. The capacity to establish continuously growing cell lines
by infecting lymphocytes with T. parva in vitro has greatly
facilitated studies of parasite-specific T-cell responses. The
parasite, therefore, offers a well-defined model system to study
the induction of CTL responses to protozoan infections and to
examine their role in immunity.
Cattle can be immunized against T. parva by infection with
sporozoite stabilates of the parasite and treatment with oxytet-
racyclines. A shortcoming of this method is that immunity
induced by one stock of the parasite does not usually extend to
all other stocks (20). The basis of this stock heterogeneity is
complex, since failure to protect is often not reciprocal be-
tween stocks and usually involves only a proportion of animals.
Hence, studies with the Muguga and Marikebuni stocks of the
parasite have shown that animals immunized with the Marike-
buni stock are protected against challenge with the Muguga
stock whereas a proportion of animals immunized with the
Muguga stock remain susceptible to challenge with the
Marikebuni stock (11, 17).
There is good evidence that the immunity induced by infec-
tion and treatment is directed against schizont-infected lym-
phoblasts and is mediated by cellular rather than humoral
immune responses (14). Remission of infection following im-
munization or challenge is associated with the detection of
potent CTL responses specific for parasitized lymphoblasts (4,
18), and these cells have been shown to be class I MHC re-
stricted, CD81, and, in some instances, parasite strain specific
(7, 18). The results of recent adoptive transfer studies utilizing
monozygotic twins have demonstrated that CD81 CTLs de-
rived from donor efferent lymph draining at the site of chal-
lenge with T. parva protected the recipient twin against para-
site infection, documenting a direct role for CTLs in protective
immunity (15). Despite the temporal relationship of the CTL
responses with clearance of infection and their observed par-
asite strain specificity, a correlation between the parasite strain
specificity of CTL and cross-protection has not been estab-
lished. This has been due partly to the lack of a sensitive assay
for measuring CTL responses in immune cattle prior to chal-
lenge and partly to parasite strain heterogeneity within some
stocks of T. parva. In the study reported herein, we have used
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a limiting-dilution (LD) analysis assay (23) to measure the
strain specificity of CTL responses in cattle immunized with
the Muguga stock or a clone derived from the Marikebuni
stock of T. parva and examined the susceptibility of these
animals to challenge with the heterologous parasite. These
experiments have demonstrated a close correlation between
the strain specificity of CTL responses and the capacity to
resist heterologous challenge.
(Portions of this work were submitted in abstract form to the
1990 British Society for Immunology meeting in London, En-
gland.)
MATERIALS AND METHODS
Animals. Twenty-three Boran (Bos indicus) steers or female animals, aged
between 8 and 42 months, were used. All cattle were reared indoors under
tick-free conditions and at the outset of the experiments were clinically normal
and negative for antibodies to T. parva.
Parasites. The ILRAD 3087 sporozoite stabilate of T. parva (Muguga) and
stabilate 3219, a cloned population of the Marikebuni stock, were used for
animal immunizations and establishment of cell lines. The latter stabilate was
derived by tick pickup from two animals infected with a twice-cloned (by LD)
parasitized cell line obtained by in vitro infection of lymphocytes with T. parva
(Marikebuni) sporozoite stabilate 3014. Previous studies involving immunofluo-
rescent staining (16) and Western blotting (immunoblotting) (25) with schizont-
specific monoclonal antibodies (MAb) (19) and DNA restriction fragment length
analysis with T. parva-specific DNA probes (2) distinguished between the Mu-
guga and Marikebuni stocks and also detected heterogeneity within the Marike-
buni stock (25). Parasite-specific MAb 2 and 3 identify Muguga, and MAb 15 and
16 identify Marikebuni (19). MAb BT5/2.2.5 identifies a schizont surface antigen
(19, 21) that differs in molecular weight (Mr) between stocks of T. parva and
between subpopulations of the Marikebuni stock. For establishment of cell lines,
sporozoites were obtained from salivary glands of ticks fed on cattle infected with
either stabilate and used to infect peripheral blood mononuclear cells in vitro (6).
Immunization and challenge of cattle. Cattle were immunized with the ap-
propriate population of parasites by simultaneous inoculation of a lethal dose of
cryopreserved sporozoite stabilate and 20 mg of long-acting tetracycline (Em-
bacycline LA; May and Baker, Ltd., Dagenham, England) per kg of body weight,
as described previously (20). The animals were challenged 5 to 8 months after
immunization with a previously determined 100% lethal dose of sporozoite
stabilate. All inoculations were subcutaneous on the right side of the neck. Cattle
were monitored for parasitosis (percent schizont-infected lymphocytes per total
number of lymphocytes in the field) by microscopic examination of smears of
aspirates of local and contralateral lymph nodes stained with fluorescein isothio-
cynate-conjugated antiserum to T. parva schizonts. Examination for parasitosis
and measurement of rectal temperature were performed daily starting from 5
days after inoculation until recovery or treatment of the animal. Parasitosis was
graded as mild (,1%), moderate (1 to 10%), or severe (.10%). A rectal
temperature of 39.58C or higher, associated with schizont parasitosis, was con-
sidered a pyrexic response. Recovery of animals was defined as disappearance of
schizonts from lymph nodes, a rectal temperature below 39.58C, and a clinically
healthy appearance.
LD culture for assay of CTLp. An LD culture system employing parasitized
cell lines as stimulator and target cells for generation and assay of cytotoxic cells,
as described previously (23), was used to measure CTL precursors (CTLp) in
peripheral blood mononuclear cells derived from immunized cattle. All cultures
were maintained in RPMI 1640 medium supplemented with 10% (vol/vol) of a
selected batch of heat-inactivated fetal calf serum (Gibco Ltd., Paisley, Scot-
land), 5 3 1025 M 2-mercaptoethanol, 2 mM L-glutamine, and 50 mg of genta-
micin per ml. Medium for culture of parasitized cell lines also contained 20 mM
HEPES (N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid) buffer at pH 7.2.
Cytotoxicity assays. Cytotoxicity generated in the LD microcultures after 7
days in culture was measured by an 111In release assay performed in V-bottom
96-well assay plates (Greiner, Nuertingen, Germany) as described previously
(22). Contents of individual wells were split into two aliquots and tested with
autologous target cells infected with the Muguga stock or clone 3219 of the
Marikebuni stock. Wells were scored as positive if they had isotope release values
three times the standard deviation above the mean of the background release
values. The natural logarithm of the fraction of negative wells was plotted against
the number of responder cells per well, and the best linear fit to the data was
obtained by computerized maximum-likelihood analysis (5). The frequency of
CTLp was then calculated directly from the gradient of the plot. Statistical
evaluation of the cytotoxicity data by this method in previous studies (23) had
shown that data conformed to the Poisson model of single-hit kinetics (24).
RESULTS AND DISCUSSION
The interpretation of results of previous studies examining
the relationship of strain specificity of CTL responses and
cross-protection following T. parva infection has been prob-
lematical because of the heterogeneity of the parasite stocks
used for challenge and the fact that parasitized cell lines used
to assay CTL activity often represent a selected component of
the parasite stock. Thus, on the basis of analyses with MAb and
DNA probes, at least five distinct parasite populations are
identifiable within the Marikebuni stock (2, 25). Moreover,
some of these populations are recognized as different by par-
asite-specific CTL clones (8). In established cell lines infected
with the Marikebuni stock, one component of the stock usually
predominates, presumably as a result of selection, and it is not
uncommon for cell lines established on the same day, with the
same batch of sporozoites, from lymphocytes of different cat-
tle, to contain different parasites (16a). Consequently, assays of
CTL responses to the Marikebuni stock using such cell lines
may detect only a component of the in vivo response and the
results obtained with different animals are not necessarily com-
parable. Moreover, when the Marikebuni stock is used for
challenge in cross-protection experiments, different compo-
nents may be responsible for breakthrough infections in dif-
ferent individual animals. Hence, a cloned population of T.
parva (Marikebuni 3219) parasites was used in the present
study. To establish that this population of parasites was indeed
homogeneous and had not changed during tick passage, and to
compare it with the Muguga stock, parasites within the cell
lines established from the animals used in the study were
analyzed with parasite-specific MAb. MAb 2 and 3 reacted at
titers of 1:3,200 or greater with all of the Muguga-infected cell
lines but gave no specific staining (titer , 1:200) with any of
the lines infected with Marikebuni 3219. Conversely, all of the
cell lines infected with Marikebuni 3219 but none of the lines
infected with Muguga reacted with MAb 15 and 16. MAb
BT5/2.2.5 was used to analyze Western blots of cell lysates
from all of the cell lines. Representative results are shown in
Fig. 1. In all of the Marikebuni 3219 lines the antigen had an
Mr of 85,000, whereas in the Muguga lines it had an Mr of
92,000. The reactivity of the MAb with the Marikebuni 3219
lines and the Mr of the antigen detected in these lines by MAb
BT5/2.2.5 are identical to those observed with the original
FIG. 1. Western blot analysis with MAb BT5/2.2.5 of lysates of 16 of 46 cell
lines infected with the Muguga stock (ä) or clone 3219 of the Marikebuni stock
(3) of T. parva is shown. The methodology followed in the analysis of these cell
lines was essentially as reported before (8). Designations above lanes refer to
some of the cattle used in the study.
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cloned cell line prior to tick passage (data not shown). These
results confirm that the Marikebuni 3219 parasite is antigeni-
cally distinct from the Muguga stock and, as far as can be
determined, is a homogeneous population.
To determine the cross-immunizing potentials of the Mu-
guga stock and clone Marikebuni 3219, two groups of cattle
were immunized and subsequently challenged with the heter-
ologous parasite. Seventeen cattle immunized against T. parva
(Muguga) and six susceptible controls were challenged with
Marikebuni 3219. Similarly, five of six animals immunized
against Marikebuni 3219, along with two susceptible controls,
were challenged with T. parva (Muguga). As shown in Tables 1
and 2, all of the challenge controls had severe reactions that
required treatment, whereas the severity of the reactions in the
immunized animals varied markedly. Six of the 17 Muguga-
immunized animals had mild or inapparent clinical reactions
with transient parasitosis that was confined to the local lymph
node and did not exceed 1% (Table 1). The remaining 11
TABLE 1. Pyrexic and parasitosis reactions in 17 T. parva (Muguga)-immune and 6 susceptible cattle following challenge with T. parva
(Marikebuni 3219)a
Animal
Pyrexia Parasitosis
Outcomeb
Day of onset Duration (days) Day of onset Duration (days)
Severity in:
Local LN Contralateral LN
Susceptible
E44 8 11 8 11 31 31 Treated
E48 10 12 10 11 31 31 Treated
E50 9 14 9 13 31 31 Treated
F153 8 13 10 12 31 31 Treated
F154 8 13 9 12 31 31 Treated
F186 6 11 7 10 31 31 Treated
Immunized
D120 12 1 12 1 11 NPS Recovered
D580 12 3 12 1 11 NPS Recovered
D761 — — 10 2 11 NPS Recovered
E49 — — 11 1 11 NPS Recovered
E98 — — 11 2 11 NPS Recovered
E292 8 4 10 3 11 NPS Recovered
D132 10 6 12 9 21 21 Recovered
D717 7 10 9 17 21 21 Recovered
E45 11 13 11 10 21 21 Recovered
E81 7 11 8 22 21 21 Recovered
E118 12 14 12 21 21 21 Recovered
E216 8 19 8 12 31 21 Recovered
E249 7 12 8 9 21 21 Recovered
E260 7 9 8 12 21 21 Recovered
F25 8 11 9 9 31 21 Recovered
F304 7 11 8 12 31 31 Treated
F339 7 11 8 9 31 31 Treated
a Abbreviations and symbols: LN, lymph node; NPS, no parasites seen; —, no pyrexia detected. 11, ,1% parasitosis (mild); 21, 1 to 10% parasitosis (moderate);
31, .10% parasitosis (severe).
b Severely reacting cattle were treated on day 16 of parasitosis.
TABLE 2. Pyrexia and parasitosis in five T. parva (Marikebuni 3219)-immune and two susceptible cattle following challenge with
T. parva (Muguga)a
Animal
Pyrexia Parasitosis
Outcomeb
Day of onset Duration (days) Day of Onset Duration (days)
Severity in:
Local LN Contralateral LN
Susceptible
G337 9 13 6 14 31 31 Treated
G338 8 8 6 11 31 31 Treated
Immunized
D540 — NA 10 1 11 ND Recovered
E59 8 10 10 9 31 ND Recovered
E82 8 12 7 13 31 ND Recovered
E212 9 2 8 1 11 ND Recovered
E259 7 1 NA NA NPS ND Recovered
a Abbreviations and symbols: NPS, no parasites seen; LN, lymph node; —, no pyrexia detected; NA, not applicable; ND, not done. 11, ,1% parasitosis (mild); 21,
1 to 10% parasitosis (moderate); 31, .10% parasitosis (severe).
b Severely reacting cattle were treated on day 16 of parasitosis.
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animals exhibited prolonged reactions with fever lasting 6 to 19
days and parasitosis detectable for 7 to 22 days. Parasitosis was
detected in both local and contralateral lymph nodes in all of
the animals and attained maximal levels of 5 to 44%. Two of
these animals required treatment, while the others recovered
naturally. Of the five Marikebuni 3219-immunized animals that
were challenged, three had mild reactions while the remaining
two cattle suffered severe reactions but eventually recovered
(Table 2). On the basis of these findings, it was concluded that
the 6 Muguga-immunized animals that had mild reactions fol-
lowing challenge with Marikebuni 3219 were protected while
the remaining 11 animals were partially or fully susceptible.
Similarly, three of the animals immunized with Marikebuni
3219 were considered to be protected while two were suscep-
tible to the Muguga challenge.
To evaluate the relationship between the specificity of CTLs
and protection against heterologous challenge, the strain spec-
ificity of CTLp in peripheral blood mononuclear cells from the
two groups of cattle was analyzed. Prior to challenge, LD
cultures were established with Muguga-infected or Marikebuni
3219-infected stimulator cells. CTLp that lysed Muguga-in-
fected target cells were detected in all of the 17 Muguga-
immunized animals at frequencies ranging from 1:14,200 to
1:2,159 (Fig. 2A). When the same effector populations were
assayed with target cells infected with Marikebuni 3219, CTLp
were undetectable in 11 animals and were detected at frequen-
cies ranging from 1:7,510 to 1:2,731 in 6 cattle. The six animals
which exhibited cross-reactive CTLp were the same animals
that were fully protected against challenge with Marikebuni
3219, as shown in Table 1. Similarly, CTLp that killed targets
infected with Marikebuni 3219 were detected at frequencies
ranging from 1:4,231 to 1:2,071 in all of the six animals immu-
nized with Marikebuni 3219 (Fig. 2B). However, when tests
were done with Muguga-infected target cells, although CTLp
were detected at comparable frequencies ranging from 1:5,502
to 1:2,867 in four animals, they were undetectable in two of the
cattle (E59 and E82). Again, those animals that had cross-
reactive CTLp were the ones which were protected against
challenge with T. parva (Muguga) (Table 2). These results
demonstrate that immunization of cattle with the Muguga
stock or the Marikebuni 3219 population of T. parva induces
strain-specific CTL responses in some individuals and cross-
reactive responses in others and, further, that the strain spec-
ificity of the CTLp correlates with protection against challenge
with the heterologous parasite. In this study, as in previous
studies (7, 23), the same cytotoxic effector cells killed target
cells infected with either parasite population in cattle which
generated cross-reactive CTL, although in all of these animals
there was an additional small population of strain-specific CTL
(data not shown), suggesting that a proportion of the effectors
in these animals recognize antigenic epitopes shared between
the two parasite populations.
The results of this study have established a clear relationship
between the parasite strain specificity of CTL responses to T.
parva in individual animals and their susceptibility to challenge
with heterologous parasite populations. The results were con-
sistent in animals immunized with one of two different parasite
populations (one being a clone) prior to challenge with the
heterologous parasite. All animals that developed cross-reac-
tive CTL responses were protected against heterologous chal-
lenge, whereas those that had strain-specific responses were
completely or partially susceptible to challenge.
Many of the animals that generated a strain-specific CTL
response eventually recovered from infection following heter-
ologous challenge. It is likely that under field conditions, when
cattle would have poor nutrition and management, more of
these animals would have succumbed to infection. Neverthe-
less, the results indicate that immunization had stimulated a
partially protective response. This may have involved the gen-
eration of low frequencies of cross-reactive CTL that were
below the level of detection by the assay. Alternatively, re-
sponses other than class I MHC-restricted CTL may have
influenced the outcome of the infection. Thus, CD41 T-cell
responses specific for parasitized cells have been demonstrated
to occur in immune animals (1). Priming of CD41 T cells
capable of providing help for the generation of CTLs may have
allowed an accelerated priming of CTLs responding to the
challenge infection, or indeed, CD41 T cells may have exerted
effector functions either directly or indirectly by recruitment of
accessory cells such as macrophages.
Previous studies (11) have demonstrated that immunization
of cattle with the Marikebuni stock results in protection against
challenge with a range of other stocks, including Muguga. It is
unclear whether this property is due to the observed hetero-
geneity within the stock and thus a capacity to induce an
immune response encompassing a range of different specifici-
ties or to the presence of a parasite component with the ability
to generate immune responses to conserved antigenic deter-
minants. Although the results of this study may favor the
former interpretation, i.e., that Marikebuni 3219, unlike the
parent Marikebuni stock, 3014, failed to protect all animals
against challenge with the Muguga stock, it is possible that
clone 3219 does not represent the component with the capacity
to generate immunity to conserved epitopes. As with Muguga-
immunized animals, this failure to protect against heterologous
challenge correlated with the detection of strain-specific CTLp
in the susceptible animals.
FIG. 2. Strain specificity of CTLp generated in individual cattle immunized
against T. parva (Muguga) (A) or T. parva (Marikebuni 3219) (B) is shown. With
the use of the LD microassay described in Materials and Methods, the frequen-
cies of CTLp recognizing autologous lymphoblasts infected with the Muguga
stock (n), clone 3219 of the Marikebuni stock (h), or either parasite stock (u)
were obtained. In all of the experiments reported herein, the correlation coef-
ficient (r2) values of CTLp frequencies were always greater than 0.85 (23). Values
of frequencies less than 1:20,000 were considered undetectable, since the re-
sponder cell input of 2 3 104 per well is the upper detection limit of the assay.
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As far as can be determined from the analyses with parasite-
specific MAb, the cloned population of the Marikebuni stock
that was used in this study was indeed antigenically homoge-
neous and the parasites in cell lines established following tick
passage were similar to those in the original cloned cell line.
Although a cloned population of the Muguga stock was not
used in the study, there is evidence that this stock is relatively
homogeneous; while some heterogeneity at the DNA level has
been detected (18a), Muguga-infected cell lines, including
those used in the present study, generally exhibit a constant
profile with MAb (16, 25) and are consistently recognized by
Muguga-specific CTL clones of the appropriate MHC restric-
tion specificities (8). Moreover, in a number of studies involv-
ing infection of animals with cloned Muguga-infected cell lines
and subsequent challenge with the parent stock, there have
been no instances of breakthrough infection (17, 18a). The
greater heterogeneity within the Marikebuni stock may reflect
the fact that it is a relatively recent field isolate in comparison
with Muguga, which has undergone repeated passages between
tick and cattle under laboratory conditions.
The finding of variation between animals in the strain spec-
ificity of CTL responses clearly indicates that individual ani-
mals respond to different antigenic epitopes and strongly sug-
gests that this response in individuals is focussed on a limited
number of epitopes. These are also characteristic features of
CTL responses to viruses in mice and humans (9, 27). The
question of what determines the variation in specificity of the
response in individual cattle has been addressed. It is well
established that in murine systems epitope selection by differ-
ent class I molecules can influence the antigenic specificity of
CTL responses (26). Although the results of work with twin
and class I MHC haplotype-related cattle immunized against
Muguga or Marikebuni 3219 indicate that the MHC phenotype
plays some role in determining the strain specificity of CTLs,
the immunizing parasite has been found to have a profound
influence on CTL specificity (unpublished data). The parasite
antigens recognized by T. parva-specific CTL have not yet been
identified, but this is also an area that is being actively inves-
tigated. The evidence provided by the present study that CTL
responses play an important role in immunity to T. parva
clearly points to the potential of utilizing the target antigens
for vaccination. Moreover, the identification of such antigens,
together with the assay systems that have been developed for
T. parva, will provide a well-defined model system to study
CTL epitope selection in intracellular protozoan parasite in-
fections.
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